Expression of connexin 43 in lung cancer and its correlation with E-cadherin

Chinese Journal of Pathology

Volumn 35, Issue 6, 2006, Pages 339-343

  Zhang, Yong Xing ^a   Xu, Hong Tao ^a   Qi, Feng Jie ^a   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell adhesion molecules; Cells, cultured; Connexin 43; Lung neoplasms

Indexed keywords

CONNEXIN 43; UVOMORULIN;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; GIANT CELL CARCINOMA; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG PARENCHYMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADULT; AGED; CADHERINS; CELL ADHESION; CELL ADHESION MOLECULES; CELL PROLIFERATION; CONNEXIN 43; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 33747056214     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nemeth L, Rolle U, Puri P. Altered cytoskeleton in smooth muscle of aganglionic bowel. Arch Pathol Lab Med, 2002, 126:692-696.
2. Chen JT, Cheng YW, Chou MC, et al. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Clin Cancer Res, 2003, 9:4200-4204.
3. Chen Y, Huhn D, Knosel T, et al. Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int J Cancer, 2005, 113:14-21.
4. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem, 2003, 278:44852-44856.
5. Ko K, Arora P, Lee W, et al. Biochemical and functional characterization of intercellular adhesion and gap junctions in fibroblasts. Am J Physiol Cell Physiol, 2000, 279:C147-C157.
6. Hernandez-Blazquez FJ, Joazeiro PP, Omori Y, et al. Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. Exp Cell Res, 2001, 270:235-247.
7. Yano T, Yamasaki H. Regulation of cellular invasion and matrix metalloprotemase activity in HepG2 cell by connexin 26 transfection. Mol Carcinog, 2001, 31:101-109.
8. Chen SC, Pelletier DB, Ao P, et al. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ, 1995, 6:681-690.
9. Huang RP, Fan Y, Hossain MZ, et al. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res, 1998, 58:5089-5096.
10. Martyn KD, Kurata WE, Warn-Cramer BJ, et al. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ, 1997, 8:1015-1027.
11. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol, 1991, 115:1357-1374.
12. Lee HJ, Lee IK, Seul KH, et al. Growth inhibition by connexin26 expression in cultured rodent tumor cells. Mol Cells, 2002, 14:136-142.
13. Zhang YW, Nakayama K, Nakayama K, et al. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res, 2003, 63:1623-1630.
14. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem, 2003, 278:44852-44856.